Alaris Equity is a quality royalty player in Canada, investing primarily in US companies. Recent results show strong net distributable cash flow and gains in book value. We identify the risks here ...

CALGARY, Alberta, April 01, 2022 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (the “Trust” and collectively with its subsidiaries “Alaris”) (TSX: AD.UN) is pleased to announce ...

Cardinal Health Inc., the nation’s second-biggest drug wholesaler, said Wednesday that it agreed to buy Alaris Medical Systems Inc. of San Diego for about $1.6 billion. Under terms of the deal ...

For the period ended March 31, 2025, Alaris generated $0.12 per unit of additional Net book value (1), improving this metric to $24.34. Driving this increase is current quarter earnings of $0.50 ...

Alaris Equity Partners has invested $30 million in 3E, a US utility service provider that installs, inspects, maintains and replaces infrastructure. It also invested $8 million in Accscient, an ...

CALGARY, Alberta, June 25, 2018 (GLOBE NEWSWIRE) — Alaris Royalty Corp. (“Alaris” or the “Corporation”) (TSX:AD) is providing an update regarding the proposed repurchase (the “Labstat ...

The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to resume distribution of its system while remediating or replacing older Alaris devices ...

Here are two top Canadian royalty stocks with dividend yields of up to 8.2%. Alaris identifies companies that raise capital for partial liquidity, growth, generational transfers, and recapitalization.